Development Agreement With Xbrane Biopharma For Xlucane

Xbrane Biopharma AB

12/07/2018 16:05

July 12 (Reuters) - STADA ARZNEIMITTEL AG  STAGn.DE :
    * XBRANE AND STADA ENTER INTO A CO-DEVELOPMENT AGREEMENT FOR
XLUCANE
    * TO ENTER INTO THIS AGREEMENT, STADA WILL MAKE AN UPFRONT
PAYMENT
TO XBRANE OF EUR 7.5 MILLION
    * CO-DEVELOPMENT AGREEMENT COVERS EUROPE, US AND A VARIETY
OF MENA
AND APAC MARKETS

Source text for Eikon:  ID:nEQbNhl6Ma 
Further company coverage:  STAGn.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))